A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 09 2021
Historique:
received: 27 05 2021
accepted: 06 09 2021
entrez: 29 9 2021
pubmed: 30 9 2021
medline: 28 12 2021
Statut: epublish

Résumé

Despite decades of use of low protein diets (LPD) in the management of chronic kidney disease (CKD), their mechanisms of action are unclear. A reduced production of uremic toxins could contribute to the benefits of LPDs. Aromatic amino-acids (AA) are precursors of major uremic toxins such as p-cresyl sulfate (PCS) and indoxyl sulfate (IS). We hypothesize that a low aromatic amino acid diet (LA-AAD, namely a low intake of tyrosine, tryptophan and phenylalanine) while being normoproteic, could be as effective as a LPD, through the decreased production of uremic toxins. Kidney failure was chemically induced in mice with a diet containing 0.25% (w/w) of adenine. Mice received three different diets for six weeks: normoproteic diet (NPD: 14.7% proteins, aromatic AAs 0.019%), LPD (5% proteins, aromatic AAs 0.007%) and LA-AAD (14% proteins, aromatic AAs 0.007%). Both LPD and LA-AAD significantly reduced proteinuria, kidney fibrosis and inflammation. While LPD only slightly decreased plasma free PCS and free IS compared to NPD; free fractions of both compounds were significantly decreased by LA-AAD. These results suggest that a LA-AAD confers similar benefits of a LPD in delaying the progression of CKD through a reduction in some key uremic toxins production (such as PCS and IS), with a lower risk of malnutrition.

Identifiants

pubmed: 34584168
doi: 10.1038/s41598-021-98718-x
pii: 10.1038/s41598-021-98718-x
pmc: PMC8479128
doi:

Substances chimiques

Amino Acids, Aromatic 0
Uremic Toxins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19184

Informations de copyright

© 2021. The Author(s).

Références

Trends Endocrinol Metab. 2015 May;26(5):256-62
pubmed: 25771038
J Am Soc Nephrol. 2014 Sep;25(9):1897-907
pubmed: 24812165
J Clin Med. 2019 Sep 10;8(9):
pubmed: 31510015
Nutr Res. 2013 Sep;33(9):761-71
pubmed: 24034576
Am J Nephrol. 2013;37(1):1-6
pubmed: 23258127
Nutrients. 2021 Apr 07;13(4):
pubmed: 33917099
Genomics. 2002 Jan;79(1):95-103
pubmed: 11827462
Cell Rep. 2018 Jul 24;24(4):935-946
pubmed: 30044989
Cell Mol Life Sci. 2018 Oct;75(20):3663-3681
pubmed: 30027295
Toxins (Basel). 2018 Apr 13;10(4):
pubmed: 29652797
Adv Nutr. 2019 Mar 1;10(2):303-320
pubmed: 30668615
Sci Rep. 2017 Sep 11;7(1):11133
pubmed: 28894133
Cell Death Discov. 2016 May 09;2:16026
pubmed: 27551517
PLoS One. 2016 Sep 06;11(9):e0162183
pubmed: 27598994
J Nutr. 2010 Sep;140(9):1646-52
pubmed: 20668252
Hypertension. 2011 Feb;57(2):269-74
pubmed: 21173345
Q J Exp Physiol. 1982 Jul;67(3):459-65
pubmed: 7111666
Curr Opin Clin Nutr Metab Care. 2016 Jan;19(1):55-61
pubmed: 26560523
Cell Rep. 2016 Jul 12;16(2):520-530
pubmed: 27346343
Nat Commun. 2018 Aug 17;9(1):3294
pubmed: 30120222
N Engl J Med. 1983 Jan 20;308(3):159-60
pubmed: 6401352
Intensive Care Med. 2017 Jun;43(6):917-920
pubmed: 28213622
Nutrition. 2018 Feb;46:26-32
pubmed: 29290351
Cochrane Database Syst Rev. 2018 Oct 04;10:CD001892
pubmed: 30284724
Curr Opin Clin Nutr Metab Care. 2017 Jan;20(1):77-85
pubmed: 27801685
Kidney Int. 2013 Feb;83(2):308-15
pubmed: 22992469
N Engl J Med. 2017 Nov 2;377(18):1765-1776
pubmed: 29091561
J Am Soc Nephrol. 2007 Oct;18(10):2653-60
pubmed: 17804674
Kidney Int. 1993 Oct;44(4):659-75
pubmed: 8258943
Clin Sci (Lond). 2018 Mar 9;132(5):509-522
pubmed: 29523750
Am J Physiol. 1986 Aug;251(2 Pt 2):F303-12
pubmed: 3740277
J Ren Nutr. 2018 May;28(3):208-214
pubmed: 29439931
Science. 2020 Sep 18;369(6510):1518-1524
pubmed: 32943527
Nat Commun. 2019 Apr 1;10(1):1476
pubmed: 30931940
BMC Nephrol. 2013 May 30;14:116
pubmed: 23718816
Kidney Int. 2000 Apr;57(4):1688-703
pubmed: 10760105
Int J Tryptophan Res. 2017 Mar 10;10:1178646917694600
pubmed: 28469469
J Clin Invest. 2016 Sep 1;126(9):3598-612
pubmed: 27525435
Nat Rev Nephrol. 2020 Sep;16(9):525-542
pubmed: 32528189
Nutrients. 2020 Dec 19;12(12):
pubmed: 33352729
Kidney Int. 2013 Apr;83(4):582-92
pubmed: 23325087
Kidney Int. 2017 Sep;92(3):634-645
pubmed: 28396122

Auteurs

Christophe Barba (C)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.
Department of Nephrology and Nutrition, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495, Pierre Bénite, France.

Bérengère Benoit (B)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.

Emilie Bres (E)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.
Department of Nephrology and Nutrition, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495, Pierre Bénite, France.

Stéphanie Chanon (S)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.

Aurélie Vieille-Marchiset (A)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.

Claudie Pinteur (C)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.

Sandra Pesenti (S)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.

Griet Glorieux (G)

Nephrology Section, Department of Internal Medicine and Pediatircs, Ghent University Hospital, Ghent, Belgium.

Cécile Picard (C)

Centre de Biologie et Pathologie Est, Hospices Civils de Lyon, Bron, France.

Denis Fouque (D)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.
Department of Nephrology and Nutrition, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495, Pierre Bénite, France.

Christophe O Soulage (CO)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France.

Laetitia Koppe (L)

CarMeN Laboratory, INSA-Lyon, INSERM U1060, INRA, Univ. Lyon, Université Claude Bernard Lyon 1, Rhône, Oullins, France. laetitia.koppe@chu-lyon.fr.
Department of Nephrology and Nutrition, Centre Hospitalier Lyon SUD, Hospices Civils de Lyon, Chemin du Grand Revoyet, 69495, Pierre Bénite, France. laetitia.koppe@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH